State Of Wisconsin Investment Board Cytom X Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.33 - $9.91 $391,194 - $612,438	-61,800 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$6.47 - $7.9 $49,819 - $60,830	-7,700 Reduced 11.08%	61,800 $405,000
Q1 2020 May 06, 2020	BUY	$3.61 - $8.6 $7,220 - $17,200	2,000 Added 2.96%	69,500 $533,000
Q3 2019 Nov 12, 2019	BUY	$7.38 - $12.25 $39,852 - $66,150	5,400 Added 8.7%	67,500 $498,000
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $13,090 - $15,974	1,400 Added 2.31%	62,100 $697,000
Q1 2019 May 13, 2019	BUY	$9.5 - $19.16 $143,450 - $289,316	15,100 Added 33.11%	60,700 $653,000
Q4 2018 Feb 11, 2019	BUY	$12.69 - $18.61 $79,947 - $117,243	6,300 Added 16.03%	45,600 $689,000
Q2 2018 Aug 03, 2018	BUY	$21.38 - $29.68 $391,254 - $543,144	18,300 Added 87.14%	39,300 $898,000
Q3 2017 Nov 01, 2017	BUY	$13.53 - $18.17 $284,130 - $381,570	21,000	21,000 $382,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.